Synapse - David Ilson

Search Within

David H Ilson

Results (86)

Intensity-modulated radiotherapy for esophageal cancer: Analysis of toxicity and outcomes

Meeting Abstract

Kurshan, N.; Ilson, D.; Shah, M. A.; Kelsen, D. P.; Ho, A. Y.; Zhang, Z.; Mo, Q.; Goodman, K. A.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Analysis of survival with modified docetaxel, cisplatin, fluorouracil (mDCF), and bevacizumab (BEV) in patients with metastatic gastroesophageal (GE) adenocarcinoma: Results of a phase II clinical trial

Meeting Abstract

Kelsen, D.; Jhawer, M.; Ilson, D.; Tse, A.; Randazzo, J.; Robinson, E.; Capanu, M.; Shah, M. A.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Diabetes mellitus (DM), serum glucose, and outcome in gastroesophageal (GE) cancer

Meeting Abstract

Feilchenfeldt, J. W.; Capanu, M.; Farooki, A.; Sully, D.; Miron, B.; Power, D. G.; Jhawer, M.; Ilson, D. H.; Kelsen, D. P.; Shah, M. A.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer

Journal Article

Ku, G. Y.; Ilson, D. H.; Schwartz, L. H.; Capanu, M.; O'reilly, E.; Shah, M. A.; Kelsen, D. P.; Schwartz, G. K.
Cancer Chemotherapy and Pharmacology (2008)

Fulltext@MSK | Save

Minimal residual local disease predicts improved survival after chemoradiotherapy in patients with squamous cell carcinoma of the esophagus

Meeting Abstract

Rizk, N. P.; Tang, L.; Park, B. J.; Flores, R.; Venkatraman, E.; Bains, M. S.; Ilson, D.; Minsky, B.; Rusch, V. W.
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save

American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma

Journal Article

Rizk, N. P.; Venkatraman, E.; Bains, M. S.; Park, B.; Flores, R.; Tang, L.; Ilson, D. H.; Minsky, B. D.; Rusch, V. W.
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save

Final results of a multicenter phase II study of irinotecan (CPT), cisplatin (CIS), and bevacizumab (BEV) in patients with metastatic gastric or gastroesophageal (GEJ) adenocarcinoma (NCI #6447)

Meeting Abstract

Shah, M. A.; Ramanathan, R. K.; Ilson, D.; Randazzo, J.; Schwartz, G. K.; Tse, A.; D'adamo, D.; Levner, A.; Capanu, M.; Kelsen, D. P.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

Phase II trial of preoperative cisplatin-irinotecan followed by concurrent cisplatin-irinotecan and radiotherapy: PET scan after induction therapy may identify early treatment failure

Meeting Abstract

Ilson, D. H.; Bains, M.; Rizk, N.; Shah, M.; Rusch, V.; Capanu, M.; Flores, R.; Kelsen, D.; Park, B.; Kepler, S.; more...
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinorna

Journal Article

Shah, M. A.; Ramanathan, R. K.; Ilson, D. H.; Levnor, A.; D'adamo, D.; O'reilly, E.; Tse, A.; Trocola, R.; Schwartz, L.; Capanu, M.; more...
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

Phase II trial of preoperative combined modality therapy for esophageal carcinoma: Induction cisplatin-irinotecan followed by concurrent cisplatinirinotecan and radiotherapy

Meeting Abstract

Tew, W. P.; Minsky, B.; Bains, M.; Rizk, N.; Rusch, V.; Kelsen, D. P.; Shah, M.; Kepler, S.; Gonen, M.; Ilson, D. H.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save